AXIM BIOTECHNOLOGIES, INC. (AXIM) › Operating IncomeAXIM BIOTECHNOLOGIES, INC. (AXIM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$505.7K2015: -$10.05M2016: -$3.76M2017: -$3.15M2018: -$5.04M2019: -$3.11M2020: -$4.95M2021: -$13.97M2022: -$4.65M2023: -$2.75M-$2.75M2014Operating Income (USD)2023Fiscal YearOperating IncomeChange YoY2023-$2.75M+40.9%2022-$4.65M+66.7%2021-$13.97M-182.4%2020-$4.95M-59.2%2019-$3.11M+38.3%2018-$5.04M-59.9%2017-$3.15M+16.2%2016-$3.76M+62.6%2015-$10.05M-1887.1%2014-$505.7K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share